SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.3350
+0.0050 (1.52%)
Aug 28, 2026, 4:10 PM AEST
SomnoMed Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 72 | 114 | 140 | 55 | 79 | 100 | |
Market Cap Growth | -53.66% | -18.90% | 157.43% | -30.96% | -21.07% | -45.25% |
Enterprise Value | 61 | 103 | 128 | 60 | 85 | 91 |
Last Close Price | 0.33 | 0.52 | 0.65 | 0.25 | 0.71 | 0.90 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Forward PE | 12.70 | 20.31 | 108.33 | 84.02 | 85.27 | 175.36 |
PS Ratio | 0.63 | 1.00 | 1.26 | 0.60 | 0.95 | 1.38 |
PB Ratio | 1.53 | 2.40 | 3.03 | 1.21 | 3.53 | 3.60 |
P/TBV Ratio | 2.89 | 4.55 | 3.72 | 1.49 | 6.03 | 5.28 |
P/FCF Ratio | 14.41 | 22.71 | 26.20 | - | - | 117.89 |
P/OCF Ratio | 8.73 | 13.76 | 18.05 | - | - | 53.91 |
PEG Ratio | 0.58 | 0.51 | 1.18 | 1.18 | 1.18 | 1.18 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.53 | 0.90 | 1.15 | 0.66 | 1.02 | 1.25 |
EV/EBITDA Ratio | 9.42 | 15.87 | 80.76 | - | - | - |
EV/EBIT Ratio | 62.38 | 105.03 | - | - | - | - |
EV/FCF Ratio | 12.14 | 20.43 | 23.85 | - | - | 106.83 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.12 | 0.12 | 0.17 | 0.15 | 1.05 | 0.43 |
Debt / EBITDA Ratio | 0.84 | 0.84 | 1.89 | - | 63.95 | - |
Debt / FCF Ratio | 1.09 | 1.09 | 1.50 | - | - | 14.14 |
Net Debt / Equity Ratio | -0.25 | -0.25 | -0.20 | -0.21 | 0.52 | -0.13 |
Net Debt / EBITDA Ratio | -1.81 | -1.81 | -5.85 | 1.46 | -5.83 | 1.35 |
Net Debt / FCF Ratio | -2.34 | -2.34 | -1.73 | 1.27 | -1.65 | -4.28 |
Asset Turnover | 1.47 | 1.47 | 1.48 | 1.39 | 1.39 | 1.27 |
Inventory Turnover | 6.02 | 6.02 | 6.53 | 7.03 | 8.82 | 10.45 |
Quick Ratio | 1.36 | 1.36 | 1.10 | 1.23 | 1.14 | 1.05 |
Current Ratio | 1.67 | 1.67 | 1.51 | 1.76 | 1.50 | 1.27 |
Return on Equity (ROE) | -5.65% | -5.65% | -7.56% | -36.31% | -31.35% | -14.77% |
Return on Assets (ROA) | 0.78% | 0.78% | -0.26% | -7.87% | -3.74% | -4.52% |
Return on Invested Capital (ROIC) | 2.74% | 2.68% | -0.86% | -23.96% | -12.41% | -18.73% |
Return on Capital Employed (ROCE) | 1.90% | 1.90% | -0.60% | -16.70% | -8.20% | -12.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -3.67% | -2.33% | -2.46% | -22.43% | -10.12% | -4.43% |
FCF Yield | 6.94% | 4.40% | 3.82% | -13.60% | -8.88% | 0.85% |
Buyback Yield / Dilution | -2.45% | -2.50% | -75.54% | -53.66% | -0.01% | -0.16% |